« Previous
Next »
Brachytherapy
Volume 8, Issue 1
, Pages 4-6
, January 2009
Counterpoint: Cesium-131: Not ready for prime time
References
- Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol. 2008;26:2278–2284
- Ultra-high dose (86.4
Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys. 2008;71:330–337 - Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys. 2007;67:327–333
- Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes. Int J Radiat Oncol Biol Phys. 2007;69:1472–1477
- 12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol. 2005;173:1562–1566
- Primary causes of death after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2008;72:433–440
- The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol. 2000;57:273–278
- (125)I monotherapy using D90 implant doses of 180
Gy or greater. Int J Radiat Oncol Biol Phys. 2008;70:96–101 - 103Pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: a 12-year experience from a single group practice. Brachytherapy. 2005;4:34–44
- Butler WM, Stewart RR, Merrick GS. A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case control study of permanent prostate brachytherapy patients. Med Phys (in press).
- Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity. Int J Radiat Oncol Biol Phys. 2005;62:981–987
- The impact of acute urinary morbidity on late urinary function after permanent prostate brachytherapy. Brachytherapy. 2007;6:258–266
- Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials. Brachytherapy. 2003;2:147–157
- The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys. 2002;54:1055–1062
- Short-term sexual function after prostate brachytherapy. Int J Cancer. 2001;96:313–319
- Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants. Med Phys. 1998;25:2293–2307
- . The “Golden Age” of prostate brachytherapy: a cautionary tale. Brachytherapy. 2008;7:55–59
- Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy. Med Phys. 2004;31:1529–1538
- . Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry. Med Phys. 2005;32:3279–3285
- . Brachytherapy dosimetry parameters calculated for a 131Cs source. Med Phys. 2007;34:754–762
PII: S1538-4721(08)00657-0
doi: 10.1016/j.brachy.2008.11.003
« Previous
Next »
Brachytherapy
Volume 8, Issue 1
, Pages 4-6
, January 2009
